Heads have turned in biotech circles with an ASX filing confirming that Platinum Asset Management has increased its stake in…
Clinical stage drug development company Syntara (ASX:SNT) is set to get a big boost in exposure within the blood cancer…
Fresh off reporting final interim data from their Phase 2 clinical trials for PXS-5505 to treat myelofibrosis, biotech company Pharmaxis…
In a potential breakthrough for the field of bone marrow cancer treatment, biotech company Pharmaxis (ASX: PXS) has released the…
A large cohort of patients around the world diagnosed with myelofibrosis (aka bone marrow cancer) will soon be able to…
There is an urgent need for better treatment for myelodysplastic syndrome (MDS), a type of blood cancer, and new research…